These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10541367)

  • 1. Strategies for developing effective radioimmunotherapy for solid tumors.
    DeNardo GL; O'Donnell RT; Kroger LA; Richman CM; Goldstein DS; Shen S; DeNardo SJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3219s-3223s. PubMed ID: 10541367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted radionuclide therapy for solid tumors: an overview.
    DeNardo SJ; Denardo GL
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S89-95. PubMed ID: 16979448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
    Burke PA; DeNardo SJ; Miers LA; Lamborn KR; Matzku S; DeNardo GL
    Cancer Res; 2002 Aug; 62(15):4263-72. PubMed ID: 12154028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunotherapy of solid cancers: A review.
    Kairemo KJ
    Acta Oncol; 1996; 35(3):343-55. PubMed ID: 8679266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy with monoclonal antibodies. A new horizon in nuclear medicine therapy?
    Sautter-Bihl ML; Bihl H
    Nuklearmedizin; 1994 Aug; 33(4):167-73. PubMed ID: 7971292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
    Wong JY; Shibata S; Williams LE; Kwok CS; Liu A; Chu DZ; Yamauchi DM; Wilczynski S; Ikle DN; Wu AM; Yazaki PJ; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5842-52. PubMed ID: 14676105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts.
    Ng B; Kramer E; Liebes L; Wasserheit C; Hochster H; Blank E; Ceriani R; Furmanski P
    Cancer Res; 2001 Apr; 61(7):2996-3001. PubMed ID: 11306478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
    Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
    Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors.
    Chatal JF; Davodeau F; Cherel M; Barbet J
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S36-40. PubMed ID: 20009292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of studies on experimental radioimmunotherapy.
    Knox SJ
    Cancer Res; 1995 Dec; 55(23 Suppl):5832s-5836s. PubMed ID: 7493355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of radioimmunotherapy in the new millennium.
    Imam SK
    Cancer Biother Radiopharm; 2001 Jun; 16(3):237-56. PubMed ID: 11471488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.
    Pedley RB; Hill SA; Boxer GM; Flynn AA; Boden R; Watson R; Dearling J; Chaplin DJ; Begent RH
    Cancer Res; 2001 Jun; 61(12):4716-22. PubMed ID: 11406542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy of the Non-Hodgkin's Lymphomas.
    Knox SJ
    Semin Radiat Oncol; 1995 Oct; 5(4):331-341. PubMed ID: 10717155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic radiotherapy using monoclonal antibodies. Options and problems].
    Sautter-Bihl ML; Wannenmacher M; Bihl H
    Strahlenther Onkol; 1993 Jun; 169(6):358-65. PubMed ID: 8316939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-guided radiation therapy of cancer.
    Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
    Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of radioimmunotherapy with response-selective peptide agonist of human C5a.
    Kurizaki T; Okazaki S; Sanderson SD; Colcher D; Enke CA; Tempero MA; Baranowska-Kortylewicz J
    J Nucl Med; 2002 Jul; 43(7):957-67. PubMed ID: 12097469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
    J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
    Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
    Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
    Sharkey RM; Goldenberg DM
    J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.